TNXP insider transaction filings
Tonix Pharmaceuticals Holding Corp. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-31. Screen TNXP transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 3 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings by 2 insiders — 3,000 shares, $40,180 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
- Largest priced transaction: purchase of 2,000 shares @ $13.79 ($27,580) by LEDERMAN SETH, filed 2026-08-31.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| LEDERMAN SETH — Chief Executive Officer, Director | 1 | 1 leg · 2,000 sh · $27,580 | — | — |
| BAGGER RICHARD H — Director | 1 | 1 leg · 1,000 sh · $12,600 | — | — |
| SAENGER BRADLEY — Chief Financial Officer | 1 | — | — | 1 |
Recent Form 4 filings — Tonix Pharmaceuticals Holding Corp.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-31 | 4 | LEDERMAN SETH — Chief Executive Officer, Director | Purchase (P): 2,000 @ $13.79 | EDGAR |
| 2026-08-24 | 4 | BAGGER RICHARD H — Director | Purchase (P): 1,000 @ $12.60 | EDGAR |
| 2026-07-09 | 4 | SAENGER BRADLEY — Chief Financial Officer | Other (J): 1,453 @ $10.91 | EDGAR |
| 2026-06-15 | 4 | Taylor Carolyn E. — Director | Purchase (P): 1,415 @ $10.55 | EDGAR |
| 2026-06-09 | 4 | LEDERMAN SETH — Chief Executive Officer, Director | Purchase (P): 5,000 @ $11.79 | EDGAR |
| 2026-06-09 | 4 | Stillwell Richard Newcomb — Director | Purchase (P): 5,000 @ $11.65 | EDGAR |
| 2026-05-14 | 4 | Stillwell Richard Newcomb — Director | Grant/award (A): 22,700 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Bell Margaret Smith — Director | Grant/award (A): 22,700 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Hunter James Randolph Jr — Director | Grant/award (A): 22,700 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Treco James — Director | Grant/award (A): 22,700 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Taylor Carolyn E. — Director | Grant/award (A): 22,700 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | BAGGER RICHARD H — Director | Grant/award (A): 22,700 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | GRANGE DAVID L — Director | Grant/award (A): 22,700 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | OLUKOTUN ADEOYE Y — Director | Grant/award (A): 22,700 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | LEDERMAN SETH — Chief Executive Officer, Director | Purchase (P): 5,000 @ $12.62 | EDGAR |
| 2026-03-18 | 4 | LEDERMAN SETH — Chief Executive Officer, Director | Purchase (P): 15,000 @ $14.89 | EDGAR |
| 2026-02-26 | 4 | MORRIS JESSICA EDGAR — Chief Operating Officer | Grant/award (A): 39,012 (derivative) @ $0 · Grant/award (A): 39,011 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | SAENGER BRADLEY — Chief Financial Officer | Grant/award (A): 39,012 (derivative) @ $0 · Grant/award (A): 39,011 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | SULLIVAN GREGORY M — Chief Medical Officer | Grant/award (A): 39,012 (derivative) @ $0 · Grant/award (A): 39,011 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | Fogarty Siobhan — Chief Technology Officer | Grant/award (A): 39,012 (derivative) @ $0 · Grant/award (A): 39,011 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | LEDERMAN SETH — Chief Executive Officer, Director | Grant/award (A): 134,504 (derivative) @ $0 · Grant/award (A): 134,503 (derivative) @ $0 | EDGAR |
| 2025-08-21 | 4 | Taylor Carolyn E. — Director | Purchase (P): 418 @ $36.03 | EDGAR |
| 2025-08-20 | 4 | Treco James — Director | Purchase (P): 250 @ $36 | EDGAR |
| 2025-06-13 | 4 | Hunter James Randolph Jr — Director | Grant/award (A): 7,740 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | LEDERMAN SETH — Chief Executive Officer, Director | Purchase (P): 4,000 @ $21.55 | EDGAR |
| 2025-05-15 | 4 | Treco James — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Bell Margaret Smith — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Taylor Carolyn E. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Stillwell Richard Newcomb — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | BAGGER RICHARD H — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | GRANGE DAVID L — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | OLUKOTUN ADEOYE Y — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | Bell Margaret Smith — Director | Other (J): 1 @ $0.15 | EDGAR |
| 2025-02-28 | 4 | Treco James — Director | Other (J): 0.02 @ $0.30 | EDGAR |
| 2025-02-28 | 4 | BAGGER RICHARD H — Director | Other (J): 0.02 @ $0.20 | EDGAR |
| 2025-02-28 | 4 | OLUKOTUN ADEOYE Y — Director | Other (J): 0.81 @ $1.91 | EDGAR |
| 2025-02-27 | 4 | SAENGER BRADLEY — Chief Financial Officer | Other (J): 0.04 @ $0 · Grant/award (A): 25,792 (derivative) @ $0 · Grant/award (A): 25,792 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | SULLIVAN GREGORY M — Chief Medical Officer | Other (J): 0.11 @ $1.47 · Grant/award (A): 29,017 (derivative) @ $0 · Grant/award (A): 29,017 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | LEDERMAN SETH — Chief Executive Officer, Director | Other (J): 5.18 @ $3.38 · Other (J): 0.22 @ $3.30 · Other (J): 1 @ $0.15 · Grant/award (A): 123,958 (derivative) @ $0 · Grant/award (A): 123,958 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | MORRIS JESSICA EDGAR — Chief Operating Officer | Other (J): 1 @ $0 · Grant/award (A): 29,291 (derivative) @ $0 · Grant/award (A): 29,291 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | Fogarty Siobhan — Chief Technology Officer | Grant/award (A): 13,500 (derivative) @ $0 · Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Treco James — Director | Grant/award (A): 104,621 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Taylor Carolyn E. — Director | Grant/award (A): 104,621 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Stillwell Richard Newcomb — Director | Grant/award (A): 104,621 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Bell Margaret Smith — Director | Grant/award (A): 104,621 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | BAGGER RICHARD H — Director | Grant/award (A): 104,621 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | GRANGE DAVID L — Director | Grant/award (A): 104,621 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | OLUKOTUN ADEOYE Y — Director | Grant/award (A): 104,621 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4/A | LEDERMAN SETH — Chief Executive Officer, Director | Grant/award (A): 235,320 (derivative) @ $0 · Grant/award (A): 1,903,680 (derivative) @ $0 · Grant/award (A): 1,309,911 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | SULLIVAN GREGORY M — Chief Medical Officer | Grant/award (A): 358,000 (derivative) @ $0 · Grant/award (A): 358,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Tonix Pharmaceuticals Holding Corp.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-22 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-07-13 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-29 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-08 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TNXP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →